HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mousumi Majumder Selected Research

Leukoplakia

11/2015Sequence and expression variations in 23 genes involved in mitochondrial and non-mitochondrial apoptotic pathways and risk of oral leukoplakia and cancer.
4/2015D-loop somatic mutations and ∼5 kb "common" deletion in mitochondrial DNA: important molecular markers to distinguish oral precancer and cancer.
2/2009Variant haplotypes at XRCC1 and risk of oral leukoplakia in HPV non-infected samples.
11/2007Increased risk of oral cancer in relation to common Indian mitochondrial polymorphisms and Autosomal GSTP1 locus.
5/2007Polymorphisms at XPD and XRCC1 DNA repair loci and increased risk of oral leukoplakia and cancer among NAT2 slow acetylators.
9/2005Increased risk of oral leukoplakia and cancer among mixed tobacco users carrying XRCC1 variant haplotypes and cancer among smokers carrying two risk genotypes: one on each of two loci, GSTM3 and XRCC1 (Codon 280).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mousumi Majumder Research Topics

Disease

20Neoplasms (Cancer)
07/2021 - 09/2005
17Breast Neoplasms (Breast Cancer)
07/2021 - 01/2012
6Leukoplakia
11/2015 - 09/2005
5Neoplasm Metastasis (Metastasis)
07/2019 - 08/2012
5Lymphatic Metastasis
01/2018 - 01/2012
4Carcinogenesis
06/2019 - 02/2009
3Inflammation (Inflammations)
02/2021 - 03/2018
3Hypoxia (Hypoxemia)
02/2021 - 07/2019
2Residual Neoplasm
09/2014 - 08/2012
2Oral Leukoplakia
10/2012 - 09/2005
2Mouth Neoplasms (Oral Cancer)
02/2009 - 11/2007
1Triple Negative Breast Neoplasms
06/2019
1Infections
02/2009

Drug/Important Bio-Agent (IBA)

8MicroRNAs (MicroRNA)IBA
07/2021 - 06/2015
7Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2019 - 08/2012
7Vascular Endothelial Growth Factor CIBA
03/2018 - 01/2012
6Biomarkers (Surrogate Marker)IBA
07/2021 - 06/2015
6Dinoprostone (PGE2)FDA Link
02/2021 - 09/2014
6Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
02/2021 - 08/2012
5Messenger RNA (mRNA)IBA
07/2020 - 02/2015
4ProstaglandinsIBA
02/2021 - 08/2012
4Proteins (Proteins, Gene)FDA Link
07/2020 - 08/2012
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
02/2021 - 08/2012
3EnzymesIBA
02/2021 - 10/2012
3Celecoxib (Celebrex)FDA Link
07/2020 - 08/2012
3Vascular Endothelial Growth Factor DIBA
01/2018 - 01/2012
3DNA (Deoxyribonucleic Acid)IBA
11/2015 - 02/2009
2Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
07/2020 - 08/2012
2Prostaglandin E Receptors (Prostaglandin E Receptor)IBA
03/2018 - 01/2018
2IntegrinsIBA
01/2018 - 01/2012
2CarcinogensIBA
11/2015 - 10/2012
2Mitochondrial DNA (mtDNA)IBA
04/2015 - 11/2007
2Codon (Codons)IBA
05/2007 - 09/2005
1WortmanninIBA
07/2020
1Reactive Oxygen Species (Oxygen Radicals)IBA
08/2019
1Estrogen ReceptorsIBA
07/2019
1Hyaluronic Acid (Hyaluronan)IBA
07/2019
1Carrier Proteins (Binding Protein)IBA
06/2019
1ElementsIBA
06/2019
1Protein Isoforms (Isoforms)IBA
06/2019
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
10/2018
1NeuropilinsIBA
01/2018
1Prostaglandin Receptors (Prostaglandin Receptor)IBA
01/2017
1Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA
01/2017
1VimentinIBA
01/2016
1Cadherins (E-Cadherin)IBA
01/2016
1Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
02/2015
1LigandsIBA
02/2015
1ChemokinesIBA
02/2015
1Chemokine ReceptorsIBA
02/2015
1CC ChemokinesIBA
02/2015
1Therapeutic UsesIBA
09/2014
1Pharmaceutical PreparationsIBA
09/2014
1CateninsIBA
09/2014
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
07/2013
1DNA AdductsIBA
10/2012
1N-acetyltransferase 1IBA
10/2012
1Indomethacin (Indometacin)FDA LinkGeneric
08/2012
14- (4- cyano- 2- (2- (4- fluoronaphthalen- 1- yl)propionylamino)phenyl)butyric acidIBA
08/2012
1ONO 8713IBA
08/2012
1matrigelIBA
08/2012
1Oncogene Proteins (Oncogene Protein)IBA
02/2009
1Leu Transfer RNAIBA
11/2007
1NucleotidesIBA
11/2007
1lysyllysine (Lys-Lys)IBA
05/2007
1DNA Repair EnzymesIBA
05/2007

Therapy/Procedure

5Therapeutics
02/2021 - 09/2014
1Intravenous Injections
06/2019
1Ligation
01/2018
1Oral Administration
08/2012